Continental Grain Company’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Continental Grain Company’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,489,242	Closed	-$1.95M	–	6
2023 Q2	$1.95M	Hold	6,489,242	–	–	0.89%	5
2023 Q1	$2.8M	Hold	6,489,242	–	–	1.36%	4
2022 Q4	$7.66M	Hold	6,489,242	–	–	2.96%	3
2022 Q3	$15.1M	Buy	6,489,242 +1,530,612	+31%	+$4.01M	6.8%	3
2022 Q2	$11M	Hold	4,958,630	–	–	4.52%	3
2022 Q1	$47.8M	Buy	+4,958,630	New	+$44.4M	27.63%	2

Continental Grain Company's GRNA Position: Q3 2023 in Review

Continental Grain Company sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 6,489,242 shares — an estimated $1.95M sold.

Continental Grain Company first reported a position in GRNA in Q1 2022 and held it in 6 quarters. The position peaked at $47.8M in Q1 2022. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

Continental Grain Company reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
Continental Grain Company sold 6,489,242 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $1.95M.
Continental Grain Company first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q1 2022 and held it in 6 quarters.
Continental Grain Company's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $47.8M in Q1 2022.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on Continental Grain Company's 13F filing for Q3 2023, filed 13 Nov 2023.